Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety assessment of intracameral T2380 during cataract surgery
2008-003279-28Phase 2Active
- Sponsor
- Laboratoires Théa
- Start
- Jun 2008
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of Mydrane in cataract (4 arms), sponsored by Laboratoires Théa. Primary endpoint: Primary efficacy endpoint. Started Jun 2008; status: active.
02
Drugs
Mydrane
03
Conditions
cataract
Beyond the preview
Go deeper on 2008-003279-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003279-28.